SCHEMBL9946029

SCHEMBL9946029

CC(C)c1ccc(OC(C)(C)C(C)(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 2/20 0.38
IDO1 P14902 2/20 0.38
PPARA Q07869 2/20 0.38
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
PDE2A O00408 1/20 0.37
TYR P14679 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 1/20 0.35
HIF1A Q16665 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
ACACB O00763 1/20 0.35
HTT P42858 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL760472 0.84 ACACB (0.46) ALDH1A1MEN1KMT2ARAB9AIDO1
SCHEMBL22839355 0.83 SLC6A2 (0.33) ALDH1A1MEN1KMT2APPARAPDE2A
Boric Acid SCHEMBL28373488 0.81 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ARAB9APPARA
SCHEMBL11951591 0.80 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ARAB9AIDO1
SCHEMBL20643732 0.80 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ARAB9AIDO1
SCHEMBL9461491 0.80 IDO1 (0.46) ALDH1A1MEN1KMT2ARAB9AIDO1
SCHEMBL9946028 0.78 KDM4E (0.44) ALDH1A1PPARGTYRSMN1; SMN2HTT
SCHEMBL84428 0.77 ALDH1A1 (0.65) ALDH1A1PDE2AMAPT
SCHEMBL24179152 0.77 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ARAB9AIDO1
SCHEMBL22764792 0.77 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ARAB9AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149693-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149693-A1 THERAPEUTIC COMPOUNDS HTR2C, GRK2, GRK3 ALDH1A1 4010/4885MEN1 4590/4885KMT2A 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.